The Antiretroviral Agent Nelfinavir Mesylate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Antiretroviral Agent Nelfinavir Mesylate

Published:2017-12-08 Issue:1 Volume:70 Page:115-126
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Sanchez Cecilia G.¹,Molinski Steven V.²,Gongora Rafael¹,Sosulski Meredith¹,Fuselier Taylor¹,MacKinnon Stephen S.²,Mondal Debasis³,Lasky Joseph A.¹

Affiliation:

1. Tulane University Health Sciences Center New Orleans Louisiana

2. Cyclica Toronto Ontario Canada

3. Tulane University School of Medicine New Orleans Louisiana

Funder

American Thoracic Society

Scleroderma Foundation

National Institutes of Health

National Institute of General Medical Sciences

Division of Rheumatology and Immunology, Medical University of South Carolina

Louisiana State University

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.40326

Reference44 articles.

1. Nelfinavir Mesylate: A Protease Inhibitor

2. Inhibition of HIV-2 Protease by HIV-1 Protease Inhibitors in Clinical Use

3. Phase I Trial of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir and Chemoradiation for Locally Advanced Pancreatic Cancer

4. HIV Drug Shows Promise as Potential Cancer Treatment

5. Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Repurposing of Clinically Approved Drugs to Target Epithelial-mesenchymal Transition Using Molecular Docking Approach;SEPTEMBER 2023;2023-09-11

2. Acidic Ionic Liquid Bridge Supported on Nano Rice Husk Ash: An Efficient Promoter for the Conversion of Nitriles to Their Corresponding 5‐Substituted 1H‐Tetrazoles and Amides;ChemistrySelect;2023-04-04

3. Microorganisms in Pathogenesis and Management of Scleroderma (Systemic Sclerosis);Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases;2022

4. Cellular and Molecular Diversity in Scleroderma;Seminars in Immunology;2021-12

5. Turning liabilities into opportunities: Off-target based drug repurposing in cancer;Seminars in Cancer Biology;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3